Glenn Sblendorio Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Glenn Sblendorio is Director of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 8,111 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $154,109. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

GLENN SBLENDORIO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$154,109 $19.0 p/Share	8,111 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$445,493 $19.0 p/Share	23,447 Reduced 100.0%	0 Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	8,111 Added 20.45%	31,558 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	7,737 Added 24.81%	23,447 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	7,029 Added 30.91%	15,710 Common Stock

Also insider at

ISEE

IVERIC bio, Inc. Healthcare

Chief Executive Officer

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

MLYS

Mineralys Therapeutics, Inc.

Director